Analyst firms · H.C. Wainwright · SPRB
H.C. Wainwright SPRB price target and rating history
Spruce Biosciences Inc. (SPRB) · Health Care
H.C. Wainwright rates Spruce Biosciences Inc. (SPRB) Neutral with a $20 price target, as of its latest action on Mar 14, 2024. It has published 3 rating actions on SPRB since July 2021, including 0 upgrades and 1 downgrade. Across 6 firms with a SPRB price target in the last 12 months, the median target is $154.50.
- Current rating
- Neutral
- Price target
- $20
- Median target, all firms
- $154.50
- Actions on SPRB
- 3
H.C. Wainwright price target on SPRB
Every H.C. Wainwright rating on SPRB
- Mar 14, 2024
- Nov 16, 2021
- Jul 19, 2021
How other firms rate SPRB
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Lake Street | Buy | $149 | Sep 17, 2026 |
| B. Riley Securities | Buy | $160 | Jul 13, 2026 |
| Guggenheim | Buy | $123 | Jun 16, 2026 |
| Craig-Hallum | Buy | $140 | Apr 27, 2026 |
| Oppenheimer | Outperform | $283 | Dec 23, 2025 |
| Leerink Partners | Outperform | $160 | Dec 3, 2025 |
Questions about H.C. Wainwright and SPRB
- What is H.C. Wainwright's price target for SPRB?
- H.C. Wainwright's latest stated price target for Spruce Biosciences Inc. (SPRB) is $20, from its action on Nov 16, 2021.
- What is H.C. Wainwright's rating on SPRB?
- H.C. Wainwright rates SPRB Neutral, a neutral rating, as of Mar 14, 2024.
- When did H.C. Wainwright last change its view on SPRB?
- On Mar 14, 2024, H.C. Wainwright downgrades to Neutral from Buy.
- How does H.C. Wainwright's SPRB target compare with other analysts?
- Across 6 firms with a SPRB price target in the last 12 months, the median target is $154.50.
More SPRB rating histories
All H.C. Wainwright ratingsSPRB news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.